Author

Fritz Aberger

University of SalzburgORCID 0000-0003-2009-6305Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Dominik P. ElmeriD· 2 shared Anshu Kumar SharmaiD· 1 shared Astrid Aufinger· 1 shared Birgit StrobliD· 1 shared Boris TichýiD· 1 shared Christina SternbergiD· 1 shared Clara Probst· 1 shared Daniel NeureiteriD· 1 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Dominik P. ElmerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 7, 2024

Hedgehog-Hippo pathway interactions promote T cell exclusion from the tumor microenvironment in basal cell carcinoma

Georg Stockmaier, Suraj R. Varkhande, Peter William Krenn…·Fritz Aberger

This study shows that HH/GLI and Hippo/YAP pathway interactions suppress T cell chemotaxis and promote immunosuppression in BCC by downregulating chemokine signaling.

DOI 10.1101/2024.07.07.602398

humanorganoid / primary culture

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedMay 29, 2024

JUN mediates senescence and immune cell recruitment to prevent prostate cancer progression

Torben Redmer, Martin Raigel, Christina Sternberg…·Lukas Kenner

This study shows JUN suppresses prostate cancer progression by inducing senescence and immune cell recruitment, with JUN depletion accelerating tumor growth.

39 citationstop 3%

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 15, 2018

Opioids trigger breast cancer metastasis through E-Cadherin downregulation and STAT3 activation promoting epithelial mesenchymal transition

Sabrina Tripolt, Vanessa M. Knab, Heidi A. Neubauer…·Daniela A. Fux

This study shows opioids promote breast cancer metastasis by reducing E-Cadherin and activating STAT3, leading to epithelial-mesenchymal transition.

DOI 10.1101/443663

humanmouse

𝕏 PostBluesky